J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2006

Papers In Press, published online ahead of print September 16, 2006
J. Lipid Res., doi:10.1194/jlr.M600212-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600212-JLR200v1
47/12/2681    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nieves, D.
Right arrow Articles by Moreno, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nieves, D.
Right arrow Articles by Moreno, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 12, 2006
Revised on September 14, 2006
Accepted on September 15, 2006

Hydroxyeicosatetraenoic acids released through cytochrome P-450 pathway regulate 3T6 fibroblast growth

Diana Nieves and Juan José Moreno

Physiology, University of Barcelona, Barcelona E-08028

Corresponding Author: jjmoreno{at}ub.edu

Eicosanoids participate in the regulation of cellular proliferation. Thus, we observed that prostaglandin E2 interaction with membrane receptors is involved in the control of 3T6 fibroblast growth induced by serum. However, our results suggested that another arachidonic acid (AA) pathway might be implicated in these events. Our results show that 3T6 fibroblast synthesized hydroxyeicosatetraenoic acids (HETEs) such as 12-HETE through cytochrome P450 (CYP450) pathway. However, 3T6 fibroblast did not produce leucotriene B4 and lipoxygenase inhibitors and leukotriene antangonists failed to inhibit 3T6 fibroblast growth induced by FBS. In contrast, we observed that CYP450 inhibitors such as SKF-525A, 17-ODYA, ABT and PPOH reduced 12(S)-HETE levels and 3T6 fibroblast growth and DNA synthesis induced by FBS. The impairment of DNA synthesis and 3T6 fibroblast growth induced by SKF-525A were reverted by exogenous addition of HETEs. Moreover, we reported that 5-HETE, 12(S)-HETE and 15(S)-HETE are mitogenic on 3T6 fibroblast in absence of another growth factor, and this effect was dependent on activation of phosphatidylinositol-3-kinase pathway. In conclusion, our results show that HETEs probably produced by CYP450 are involved in the control of 3T6 fibroblast growth.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C.-J. Liang, H. E. Ives, C.-M. Yang, and Y.-H. Ma
20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-
J. Lipid Res., January 1, 2008; 49(1): 66 - 73.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.